These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29028088)

  • 1. Antitumor effect of miR-27b-3p on lung cancer cells via targeting Fzd7.
    Sun Y; Xu T; Cao YW; Ding XQ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4113-4123. PubMed ID: 29028088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
    Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7.
    Geng Y; Lu X; Wu X; Xue L; Wang X; Xu J
    Oncol Rep; 2016 Apr; 35(4):2441-50. PubMed ID: 26780940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
    Fan Q; Hu X; Zhang H; Wang S; Zhang H; You C; Zhang CY; Liang H; Chen X; Ba Y
    Cell Physiol Biochem; 2017; 44(4):1311-1324. PubMed ID: 29183007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway.
    Liu B; Chen W; Cao G; Dong Z; Xu J; Luo T; Zhang S
    Arch Oral Biol; 2017 Nov; 83():92-96. PubMed ID: 28735227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.
    Sun XX; Zhang SS; Dai CY; Peng J; Pan Q; Xu LF; Ma XL
    Cell Physiol Biochem; 2017; 44(3):1093-1105. PubMed ID: 29179212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
    Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
    Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.
    Deng B; Zhang Y; Zhang S; Wen F; Miao Y; Guo K
    Tumour Biol; 2015 Sep; 36(10):8065-73. PubMed ID: 25976503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.
    Jia XP; Meng LL; Fang JC; Wang HW; Chen J; Zhou J; Wang CN; Jiang WF
    Clin Lab; 2018 Jun; 64(6):915-921. PubMed ID: 29945308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9.
    Liu CQ; Chen Y; Xie BF; Li YL; Wei YT; Wang F
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5628-5639. PubMed ID: 31298315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3.
    Wang M; Meng B; Liu Y; Yu J; Chen Q; Liu Y
    Cell Physiol Biochem; 2017; 44(5):2017-2028. PubMed ID: 29237164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-216a-3p regulates the proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2.
    Wang X; Shi J; Niu Z; Wang J; Zhang W
    Biosci Biotechnol Biochem; 2020 Oct; 84(10):2014-2027. PubMed ID: 32619135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MicroRNA-124 Polymorphism is Associated with Fracture Healing via Modulating BMP6 Expression.
    Zou L; Zhang G; Liu L; Chen C; Cao X; Cai J
    Cell Physiol Biochem; 2017; 41(6):2161-2170. PubMed ID: 28441666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.
    Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1.
    Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y
    Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/β-catenin pathway in non-small cell lung cancer.
    Wang B; Sun L; Li J; Jiang R
    Mol Med Rep; 2018 Sep; 18(3):2753-2761. PubMed ID: 30015869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑613 inhibits proliferation and invasion of renal cell carcinoma cells through targeting FZD7.
    Song H; Nan Y; Wang X; Zhang G; Zong S; Kong X
    Mol Med Rep; 2017 Oct; 16(4):4279-4286. PubMed ID: 29067457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of miR-338-3p and Impact of its Suppression on Cell Metastasis Through N-Cadherin Accumulation at the Cell -Cell Junction and Degradation of MMP in Gastric Cancer.
    Guo B; Zhang J; Li Q; Zhao Z; Wang W; Zhou K; Wang X; Tong D; Zhao L; Yang J; Huang C
    Cell Physiol Biochem; 2018; 50(2):411-425. PubMed ID: 30308487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.